SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2021 |
| Outros Autores: | , , , , , , , , , , , , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
| Texto Completo: | https://www.arca.fiocruz.br/handle/icict/51718 |
Resumo: | Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| id |
CRUZ_216b1a4cfda3508dbd3743228660995b |
|---|---|
| oai_identifier_str |
oai:www.arca.fiocruz.br:icict/51718 |
| network_acronym_str |
CRUZ |
| network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| repository_id_str |
2135 |
| spelling |
Lalwani, PriteshSalgado, Bárbara BatistaPereira Filho, Ivanildo VieiraSilva, Danielle Severino Sena daMorais, Thiago Barros do Nascimento deJordão, Maele FerreiraBarbosa, , Aguyda Rayany CavalcanteCordeiro, Isabelle BezerraSouza Neto, Júlio Nino deAssunção, Enedina Nogueira deSantos, Rafaella Oliveira dosCarvalho, Nani OliveiraSalgado Sobrinho, Wlademir BragaCosta, Cristiano Fernandes daSouza, Pedro Elias deAlbuquerque, Bernardino Claudio deGanoza, Christian A.Araujo-Castillo, Roger V.Astofi Filho, SpartacoLalwani, Jaila Dias Borges2022-03-17T13:33:33Z2022-03-17T13:33:33Z2021LALWANI, Pritesh et al. SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study. International Journal of Infectious Diseases, [s. l.], v. 110, p. 141-150, 2021.1201-9712https://www.arca.fiocruz.br/handle/icict/5171810.1016/j.ijid.2021.07.017Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.Antecedentes: Manaus, localizada na floresta tropical brasileira, passou por dois colapsos do sistema de saúde devido à pandemia da doença de coronavírus 2019 (COVID-19). No entanto, pouco se sabe sobre quais grupos entre a população em geral foram os mais afetados. Métodos: Uma estratégia de amostragem de conveniência por meio de publicidade online recrutou 3.046 adultos entre 19 de agosto de 2020 e 2 de outubro de 2020. Características sociodemográficas, sintomas relacionados ao COVID-19, COVID-19 testes, automedicação e medicamentos prescritos foram registrados. Soro anti-respiratório agudo grave anticorpos da imunoglobulina G do nucleocapsídeo da síndrome coronavírus-2 (SARS-CoV-2) foram medidos com um ensaio imunossorvente ligado a enzima. As razões de prevalência (RP) foram obtidas usando correção de cluster e modelos de regressão de Poisson ajustados. Resultados: A taxa bruta de positividade entre indivíduos assintomáticos e sintomáticos foi estimada em 29,10%, com soroprevalência máxima possível de 44,82% corrigida pelas características do teste e taxa de decaimento de anticorpos de 32,31%. Os modelos de regressão demonstraram uma forte associação com os marginalizados. moradores de baixa renda e vulneráveis com acesso limitado aos cuidados de saúde. A presença de um COVID-19 caso [RP 1,39, intervalo de confiança de 95% (IC) 1,24–1,57] ou morte (RP 2,14, IC 95% 1,74–2,62) em uma família aumentou muito o risco de outros membros da família adquirirem infecção. A soroprevalência de O SARS-CoV-2 foi maior entre aqueles que se automedicaram para prevenir a infecção (PR 1,36, IC 95% 1,27–1,46). Conclusões: Observou-se disparidade socioeconômica desproporcional entre os participantes do estudo. O natureza sindêmica do COVID-19 na região amazônica precisa de políticas diferenciadas e soluções urgentes para controlar a pandemia em curso.Background: Manaus, located in the Brazilian rainforest, has experienced two health system collapses due to the coronavirus disease 2019 (COVID-19) pandemic. However, little is known about which groups among the general population have been most affected. Methods: A convenience sampling strategy via online advertising recruited 3046 adults between 19 August 2020 and 2 October 2020. Sociodemographic characteristics, COVID-19-related symptoms, COVID-19 testing, self-medication and prescribed medications were recorded. Serum anti-severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) nucleocapsid immunoglobulin G antibodies were measured with an enzyme-linked immunosorbent assay. Prevalence ratios (PR) were obtained using cluster-corrected and adjusted Poisson’s regression models. Results: A crude positivity rate among asymptomatic and symptomatic individuals was estimated at 29.10%, with maximum possible seroprevalence of 44.82% corrected by test characteristics and an antibody decay rate of 32.31%. Regression models demonstrated a strong association towards marginalized low-income and vulnerable residents with limited access to health care. The presence of a COVID-19 case [PR 1.39, 95% confidence interval (CI) 1.24–1.57] or death (PR 2.14, 95% CI 1.74–2.62) in a household greatly increased the risk of other household members acquiring infection. The seroprevalence of SARS-CoV-2 was higher among those who self-medicated to prevent infection (PR 1.36, 95% CI 1.27–1.46). Conclusions: Disproportionate socio-economic disparity was observed among the study participants. The syndemic nature of COVID-19 in the Amazon region needs differential policies and urgent solutions to control the ongoing pandemic.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Manaus, AM, Brasil.Universidade Federal do Amazonas. Instituto de Ciências Biológicas. Manaus, AM, Brasil.Universidade Federal do Amazonas. Centro de Apoio Multidisciplinar. Manaus, AM, Brasil.Universidade Federal do Amazonas. Centro de Apoio Multidisciplinar. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Manaus, AM, Brasil.Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Manaus, AM, Brasil.Fundação de Vigilância em Saúde do Amazonas. Manaus, AM, Brasil.Universidade Federal do Amazonas. Faculdade de Medicina. Programa de Pós – Graduação em Cirurgia. Manaus, AM, Brasil.Universidade Federal do Amazonas. Faculdade de Medicina. Manaus, Amazonas, Brasil.Universidad Peruana Cayetano Heredia. Instituto de Medicina Tropical Alexander von Humboldt. Lima, Peru.Universidad Peruana de Ciencias Aplicadas. Facultad de Ciencias de la Salud, Lima, Peru.Universidade Federal do Amazonas. Instituto de Ciências Biológicas. Manaus, AM, Brasil.Universidade Federal do Amazonas. Faculdade de Ciências Farmacêuticas. Manaus, AM, Brasil.engCOVID-19SARS-CoV-2AmazonasEpidemiologiaSoroprevalênciaCOVID-19SARS-CoV-2AmazonEpidemiologySeroprevalenceCOVID-19SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort studyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83082https://www.arca.fiocruz.br/bitstream/icict/51718/1/license.txt43cf57123dace9a28c9f6b2c996fa81bMD51ORIGINALArticle Lalwani et al 2021.pdfArticle Lalwani et al 2021.pdfapplication/pdf536110https://www.arca.fiocruz.br/bitstream/icict/51718/2/Article%20Lalwani%20et%20al%202021.pdff6d64e57291349ed693314203444a316MD52icict/517182022-03-25 22:31:11.313oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352022-03-26T01:31:11Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
| dc.title.pt_BR.fl_str_mv |
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study |
| title |
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study |
| spellingShingle |
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study Lalwani, Pritesh COVID-19 SARS-CoV-2 Amazonas Epidemiologia Soroprevalência COVID-19 SARS-CoV-2 Amazon Epidemiology Seroprevalence COVID-19 |
| title_short |
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study |
| title_full |
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study |
| title_fullStr |
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study |
| title_full_unstemmed |
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study |
| title_sort |
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study |
| author |
Lalwani, Pritesh |
| author_facet |
Lalwani, Pritesh Salgado, Bárbara Batista Pereira Filho, Ivanildo Vieira Silva, Danielle Severino Sena da Morais, Thiago Barros do Nascimento de Jordão, Maele Ferreira Barbosa, , Aguyda Rayany Cavalcante Cordeiro, Isabelle Bezerra Souza Neto, Júlio Nino de Assunção, Enedina Nogueira de Santos, Rafaella Oliveira dos Carvalho, Nani Oliveira Salgado Sobrinho, Wlademir Braga Costa, Cristiano Fernandes da Souza, Pedro Elias de Albuquerque, Bernardino Claudio de Ganoza, Christian A. Araujo-Castillo, Roger V. Astofi Filho, Spartaco Lalwani, Jaila Dias Borges |
| author_role |
author |
| author2 |
Salgado, Bárbara Batista Pereira Filho, Ivanildo Vieira Silva, Danielle Severino Sena da Morais, Thiago Barros do Nascimento de Jordão, Maele Ferreira Barbosa, , Aguyda Rayany Cavalcante Cordeiro, Isabelle Bezerra Souza Neto, Júlio Nino de Assunção, Enedina Nogueira de Santos, Rafaella Oliveira dos Carvalho, Nani Oliveira Salgado Sobrinho, Wlademir Braga Costa, Cristiano Fernandes da Souza, Pedro Elias de Albuquerque, Bernardino Claudio de Ganoza, Christian A. Araujo-Castillo, Roger V. Astofi Filho, Spartaco Lalwani, Jaila Dias Borges |
| author2_role |
author author author author author author author author author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Lalwani, Pritesh Salgado, Bárbara Batista Pereira Filho, Ivanildo Vieira Silva, Danielle Severino Sena da Morais, Thiago Barros do Nascimento de Jordão, Maele Ferreira Barbosa, , Aguyda Rayany Cavalcante Cordeiro, Isabelle Bezerra Souza Neto, Júlio Nino de Assunção, Enedina Nogueira de Santos, Rafaella Oliveira dos Carvalho, Nani Oliveira Salgado Sobrinho, Wlademir Braga Costa, Cristiano Fernandes da Souza, Pedro Elias de Albuquerque, Bernardino Claudio de Ganoza, Christian A. Araujo-Castillo, Roger V. Astofi Filho, Spartaco Lalwani, Jaila Dias Borges |
| dc.subject.other.pt_BR.fl_str_mv |
COVID-19 SARS-CoV-2 Amazonas Epidemiologia Soroprevalência |
| topic |
COVID-19 SARS-CoV-2 Amazonas Epidemiologia Soroprevalência COVID-19 SARS-CoV-2 Amazon Epidemiology Seroprevalence COVID-19 |
| dc.subject.en.pt_BR.fl_str_mv |
COVID-19 SARS-CoV-2 Amazon Epidemiology Seroprevalence |
| dc.subject.decs.pt_BR.fl_str_mv |
COVID-19 |
| description |
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| publishDate |
2021 |
| dc.date.issued.fl_str_mv |
2021 |
| dc.date.accessioned.fl_str_mv |
2022-03-17T13:33:33Z |
| dc.date.available.fl_str_mv |
2022-03-17T13:33:33Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
LALWANI, Pritesh et al. SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study. International Journal of Infectious Diseases, [s. l.], v. 110, p. 141-150, 2021. |
| dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/51718 |
| dc.identifier.issn.pt_BR.fl_str_mv |
1201-9712 |
| dc.identifier.doi.none.fl_str_mv |
10.1016/j.ijid.2021.07.017 |
| identifier_str_mv |
LALWANI, Pritesh et al. SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study. International Journal of Infectious Diseases, [s. l.], v. 110, p. 141-150, 2021. 1201-9712 10.1016/j.ijid.2021.07.017 |
| url |
https://www.arca.fiocruz.br/handle/icict/51718 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
| instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
| instacron_str |
FIOCRUZ |
| institution |
FIOCRUZ |
| reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| collection |
Repositório Institucional da FIOCRUZ (ARCA) |
| bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/51718/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/51718/2/Article%20Lalwani%20et%20al%202021.pdf |
| bitstream.checksum.fl_str_mv |
43cf57123dace9a28c9f6b2c996fa81b f6d64e57291349ed693314203444a316 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
| repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
| _version_ |
1798324807572389888 |